Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

By J. Llovet, T. de Baère, L. Kulik, Philipp K. Haber, T. Greten, T. Meyer, Riccardo Lencioni. Nature reviews: Gastroenterology & hepatology, 2021

840 citations recorded by the source corpus.

Subfields: Cell Biology, Hepatology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/d4feb714bca1de181f46b52b4be257b3468c2226

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hepatology

1. V. Mazzaferro
2. Andrew X. Zhu
3. R. Finn
4. J. Llovet
5. Jordi Bruix1 , 2
6. Riccardo Lencioni

In Pathology and Forensic Medicine

1. Andrew X. Zhu
2. V. Mazzaferro
3. J. Llovet

Citations in the corpus

• Immunotherapies for hepatocellular carcinoma (2021, background): “Kupffer cells, which constitute up to 90% of liver macrophages, and other TAMs can contribute to hepatocarcinogenesis and immune evasion through several mechanisms, including (1) secretion of IL-10 and other immunosuppressive cytokines in response to antigens and damageassociated or microbiomederive”